Biobanked Liver Organoids: A Roadmap for Precision Hepatology

Cryopreservation-enabled workflows decouple tissue acquisition from organoid generation, allowing archived biopsies and surgical explants to be revisited as renewable experimental models. This shift expands access to patient-specific material, reduces the logistical and batch variability inherent in fresh-tissue pipelines, and enables retrospective and longitudinal studies anchored in real-world clinical cohorts. Proof-of-concept studies show that liver organoids can be derived from cryopreserved human tissues that retain viability and disease-relevant phenotypes, but performance remains sensitive to the source material, culture lines, and protocol details. The field remains fragmented, lacking broadly adopted standard operating procedures, shared post-thaw quality benchmarks, and interoperable data infrastructures linking organoid biobanks to clinical metadata. In this work, we argue that cryopreservation-enabled organoid biobanking should be treated as foundational infrastructure for precision hepatology, and we outline a pragmatic roadmap for coordinated implementation over the next decade.